-
Clinical characteristics
Time frame: At baseline, and at 3, 6 and 12 months after the initiation of the intervention
Levels of glucose: mg/dL (milligrams per deciliter).
-
Clinical characteristics
Time frame: At baseline, and at 3, 6 and 12 months after the initiation of the intervention
Glycosylated hemoglobin (HbA1c): % (percentage).
-
Clinical characteristics
Time frame: At baseline, and at 3, 6 and 12 months after the initiation of the intervention
Homeostasis model assessment-insulin resistance (HOMA-IR): Dimensionless unit.
-
Clinical characteristics
Time frame: At baseline, and at 3, 6 and 12 months after the initiation of the intervention
Total cholesterol: mg/dL (milligrams per deciliter).
-
Clinical characteristics
Time frame: At baseline, and at 3, 6 and 12 months after the initiation of the intervention
High-density lipoprotein cholesterol (HDL-c): mg/dL (milligrams per deciliter).
-
Clinical characteristics
Time frame: At baseline, and at 3, 6 and 12 months after the initiation of the intervention
Low-density lipoprotein cholesterol (LDL-c): mg/dL (milligrams per deciliter).
-
Clinical characteristics
Time frame: At baseline, and at 3, 6 and 12 months after the initiation of the intervention
Triglycerides (TG): mg/dL (milligrams per deciliter).
-
Clinical characteristics
Time frame: At baseline, and at 3, 6 and 12 months after the initiation of the intervention
Aspartate aminotransferase (AST): U/L (units per liter).
-
Clinical characteristics
Time frame: At baseline, and at 3, 6 and 12 months after the initiation of the intervention
Alanine aminotransferase (ALT): U/L (units per liter).
-
Clinical characteristics
Time frame: At baseline, and at 3, 6 and 12 months after the initiation of the intervention
Gamma-glutamyl transferase (GGT): U/L (units per liter).
-
Clinical characteristics
Time frame: At baseline, and at 3, 6 and 12 months after the initiation of the intervention
Creatinine: mg/dL (milligrams per deciliter).
-
Clinical characteristics
Time frame: At baseline, and at 3, 6 and 12 months after the initiation of the intervention
Urea: mg/dL (milligrams per deciliter.
-
Clinical characteristics
Time frame: At baseline, and at 3, 6 and 12 months after the initiation of the intervention
Creatinine clearance: mL/min (milliliters per minute).
-
Clinical characteristics
Time frame: At baseline, and at 3, 6 and 12 months after the initiation of the intervention
Iron: µg/dL (micrograms per deciliter).
-
Clinical characteristics
Time frame: At baseline, and at 3, 6 and 12 months after the initiation of the intervention
Ferritin: ng/mL (nanograms per milliliter).
-
Clinical characteristics
Time frame: At baseline, and at 3, 6 and 12 months after the initiation of the intervention
Sodium: mmol/L (millimoles per liter).
-
Clinical characteristics
Time frame: At baseline, and at 3, 6 and 12 months after the initiation of the intervention
Potassium: mmol/L (millimoles per liter).
-
Clinical characteristics
Time frame: At baseline, and at 3, 6 and 12 months after the initiation of the intervention
C-reactive protein (CRP): mg/L (milligrams per liter).
-
Blood pressure
Time frame: At baseline, and at 3, 6 and 12 months after the initiation of the intervention
Measurements will be taken over the brachial artery, after 5 minutes of rest while seated and with the arms resting at heart level. Long-sleeved shirts will be removed for a correct reading and the cuff size must be adequate.
-
Anthropometric data
Time frame: At baseline, and at 3, 6 and 12 months after the initiation of the intervention
Anthropometric measurements of weight are collected by healthcare personnel using calibrated instruments and clinical standard procedures. Weight will be measured in kilograms (kg).
-
Anthropometric data
Time frame: At baseline, and at 3, 6 and 12 months after the initiation of the intervention
Anthropometric measurements of height are collected by healthcare personnel using calibrated instruments and clinical standard procedures. Height will be measured in centimeters (cm).
-
Anthropometric data
Time frame: At baseline, and at 3, 6 and 12 months after the initiation of the intervention
Weight and height will be combined to report the BMI in kg/m².
-
Anthropometric data
Time frame: At baseline, and at 3, 6 and 12 months after the initiation of the intervention
Anthropometric measurements of waist-hip circumference are collected by healthcare personnel using calibrated instruments and clinical standard procedures. Waist-hip circumference will be measured in centimeters (cm).